Anthropic’s $2 Trillion Question Lands at the Worst Possible Moment
With a mid-October IPO window closing in on election week, the gap between private ambition and public-market reality is about…
With a mid-October IPO window closing in on election week, the gap between private ambition and public-market reality is about…
September 7, 2026 When a historically dovish house capitulates on easing, crowded trades on the...
September 7, 2026 Bonus Content: South Korea Already Told You What Tuesday’s China Trade Numbers...
A 93% revenue surge and a PwC deal cement Palantir’s commercial AI position, but a forward multiple above 110x still…
Congo's concentrate export ban, Chile down 9.4%, and TC/RCs at zero keep the squeeze tight for FCX and SCCO.
September 6, 2026 Friday’s split session, Russell 2000 green while the S&P 500, Dow, and...
September 6, 2026 Bonus Content: Fastenal’s best sales month in 4 years vs. ISM’s warning...
A melanoma Phase 3 win and an FDA-approved flu vaccine give Moderna its first credible platform since COVID. The stock…
Constellation has 20-year deals with Microsoft and Meta, a restart advancing, and a $5B buyback. The stock has barely noticed.
September 5, 2026 When a top S&P 500 stock rallies into hawkish payrolls, the positioning...